Biotechnology in Scotland is stepping out of the shadows. No longer a specialist sector, it has become an essential lever for public health, climate resilience and economic renewal. Life sciences now touch every aspect of modern life, from infection prevention and advanced diagnostics to sustainable materials and digital therapeutics. But if we want biotech to power Scotland’s future, we need to do more than celebrate breakthroughs. We need to connect them.

Scotland’s ecosystem is rich with outstanding universities, NHS-linked research hubs and a growing cohort of entrepreneurial biotech ventures. Yet challenges persist. Translating research into real-world impact remains slow. Early-stage companies face funding fragility and talent retention issues. Regulatory complexity limits market access. And too often, success stories are hidden behind technical language or lack the visibility to inspire and attract global partners.

In the rapidly evolving biotechnology sector, scaling from start-up to global contender presents a myriad of challenges. These challenges are not insurmountable but rather opportunities to propel growth and establish a presence on the world stage.

As I prepare to take part in a panel discussion at this week’s IBioIC conference in Glasgow, I wanted to share my insights on the critical importance of seizing opportunities for international visibility, the strength of Scottish talent, and the lessons learned from recent endeavours.